# seroconversion

<p><span class="chinese">有没有一年半后血清转阳的个案？</span><span class="english">Is there any seroconversion lasting more than a year and a half ?</span></p>

<p><span class="chinese">理想终点是抗原消失或甚至产生HBsAb血清转换。</span><span class="english">The ideal end point is antigen loss or even seroconversion to anti-HBs.</span></p>

<p><span class="chinese">但效果是太多的非特异性，很少会导致间隙和血清转换。</span><span class="english">But the effect is too unspecific and will rarely lead to clearance and seroconversion.</span></p>

<p><span class="chinese">PRRS毒血清转换和毒血症通常发生在生产育苗阶段。</span><span class="english">PRRSV seroconversion and viremia typically occur during the nursery phase of production.</span></p>

<p><span class="chinese">治疗终点就是要降低病毒血症，然后获得抗原的血清转化。</span><span class="english">The end point of a new therapy is to decline, decrease viremia and to achieve the antigen seroconversion.</span></p>

<p><span class="chinese">即使这些人血清转化的“延迟”在医学专业领域也饱受争议。</span><span class="english">Even this "delayed" seroconversion among this small population is highly debated among medical professionals.</span></p>

<p><span class="chinese">半乳糖苷酶是实现B→O血型转变、制备通用型血的关键工具酶。</span><span class="english">Alpha galactosidase is an important enzyme for seroconversion from group B to universal group O of human red blood cells.</span></p>

<p><span class="chinese">目的探讨接种狂犬病疫苗后抗体阳转率及其相关因素。</span><span class="english">Objective To investigate the seroconversion rate of antibody after rabies vaccine inoculation and the its related factors.</span></p>

<p><span class="chinese">我们应该增加患者的病毒应答率以便达到表面抗原消失、表面抗原血清转化、乃至彻底治愈乙肝。</span><span class="english">We should increase the persontation patient with good complete virological response and induce more HBs antigen loss and seroconversion more cure.</span></p>

<p><span class="chinese">方法观察367名接种卡介苗后满12周儿童卡痕形成情况，并对其纯蛋白衍生物试验阳转结果进行分析。</span><span class="english">Methods To observe the scar shapes of 367 infants aged 12 weeks after BCG vaccination and to analyze the purified protein derivative seroconversion results.</span></p>

<p><span class="chinese">需要进一步研究，在较大的患者人群，以确定最佳端点停止口服慢性乙型肝炎治疗，最大限度地实现持久的血清转换和病毒抑制。</span><span class="english">Further studies are needed in larger patient populations to determine the best endpoint for stopping oral CHB therapy, to maximize durable seroconversion and viral suppression.</span></p>

<p><span class="chinese">最后，有伴有和不伴有并发症的病人中前C区变异的发生率无差异。</span><span class="english">The development of cirrhosis related complications and HCC was unrelated to precore mutations, but was probably due to the persistence of significant viremia after HBeAg seroconversion.</span></p>

